Emcure Pharma IPO subscribed 3.36 times on Day 2 so far; GMP inches higher
The initial public offering (IPO) of Emcure Pharmaceutical saw a decent response from the investors during the second day of the bidding process. After being fully subscribed on the first day itself, the issue continued to attract investors from retail, HNI and employee categories. The Pune-based Emcure Pharmaceuticals is selling its shares in the price …